ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 48229 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 48229; 2) Community: the network communities that were significantly associated with the response to NSC 48229; 3) Molecule: the relationships between components within communities and NSC 48229; 4) MDR: the compounds that were significantly associated with the NSC 48229.

NSC Compound Enrichment Correlation
NSC 728038 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline 0.0342636096654271 -0.21893042
NSC 730868 (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one 0.0342636096654271 -0.24721345
NSC 733504 Everolimus 0.0342636096654271 0.13547432
NSC 736041 7-(5-diethylaminopentyloxy)-5-hydroxy-2-phenyl-4H-4-chromeno ne 0.0342636096654271 -0.16600029
NSC 737231 Null 0.0342636096654271 -0.13643062
NSC 740 Methotrexate 0.0342636096654271 -0.24689633
NSC 748715 Null 0.0342636096654271 0.034192981
NSC 751152 3-(6/7-trifluoro-3-methyl-1,4-dioxy-quinoxaline-2-yl)-1-(3,4,5-trimethoxy-phenyl)-propenone 0.0342636096654271 -0.3212925
NSC 759178 Pipamperone 0.0342636096654271 -0.05170206
NSC 763703 (Z)-6-chloro-3-((2-(4-methoxyphenyl)-3H-benzo[d]imidazol-5-yl)methylene)indolin-2-one 0.0342636096654271 -0.16394797
Total:111  Current:85    [First] [Prev] [Next] [Last]